Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma
Clinical trial NCT04890106 · COMPLETED
Trial details
- NCT number
- NCT04890106
- Sponsor
- Mankind Pharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-02
- Primary completion
- 2022-08-11
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.